Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
La Revue De Medecine Interne|January 28, 2012
[Evans syndrome: be careful of over-diagnosis]H Eddou, C Helissey, J Konopacki, et al.Acta Haematologica|January 7, 2010
Which role for rituximab in hairy cell leukemia? Reflections on six casesJ V Malfuson, T Fagot, J Konopacki, et al.La Revue De Medecine Interne|February 10, 2009
[Hematological disorders and hypereosinophilias]J-V Malfuson, T Fagot, J Konopacki, et al.Annals of Hematology|July 24, 2012
Fractionated doses of gemtuzumab ozogamicin combined with 3 + 7 induction chemotherapy as salvage treatment for young patients with acute myeloid leukemia in first relapseJ V Malfuson, J Konopacki, C Thepenier, et al.Revue De Pneumologie Clinique|October 12, 2010
[Acute respiratory distress revealing acute myeloblastic leukaemia: case report]J-V Malfuson, J Margery, A Bonnichon, et al.Annales De Chirurgie Plastique Et Esthetique|January 2, 2018
Complex upper arm reconstruction using an antero-lateral thigh free flap after an extravasation of Yttrium-90-ibritumomab Tiuxetan: A case report and literature reviewA Baus, C Keilani, C-S Bich, et al.La Revue De Medecine Interne|November 1, 2019
[Autoimmune hemolytic anemia and immune thrombocytopenia associated with Hodgkin disease: Retrospective monocentric study]W Caré, P Arnautou, A Segot, et al.Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 28, 2007
[ABO incompatibility and non myeloablative allogeneic stem cell transplantation]J-V Malfuson, Y Hicheri, P Bonin, et al.Vox Sanguinis|December 22, 2006
Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO-incompatible allogeneic haematopoietic stem cell transplantationJ-V Malfuson, R B Amor, P Bonin, et al.Presse Medicale (Paris, France : 1983)|March 31, 2005
[Hodgkin's disease with bone marrow involvement. The role of positron tomography]K Doghmi, J-V Malfuson, M El Ouennass, et al.Pageof 2